TYNDALL CAPITAL PARTNERS L P Insider Profile
4 Followers
TYNDALL CAPITAL PARTNERS L P, Ten Percent Owner at Traws Pharma, holds 616.39K shares in Traws Pharma (Ticker: TRAW). Most recently, TYNDALL CAPITAL PARTNERS L P Sold 16,700 shares of Traws Pharma on Sep 26, 2019 for an estimated value of $19.87K.
TYNDALL CAPITAL PARTNERS L P's Trading History
| TRAWTraws Pharma | Sep 26, 2019 | Ten Percent Owner | Informative Sell | 19.87K | $154.71K | |
TRAW Insider Shares: 616.39K (10.28%) | ||||||
You May Also Like
TYNDALL CAPITAL PARTNERS L P insider profile FAQ
What is the percentage of profitable transactions made by TYNDALL CAPITAL PARTNERS L P?
The percentage of profitable transactions made by TYNDALL CAPITAL PARTNERS L P is 75%.
What is the average return per transaction made by TYNDALL CAPITAL PARTNERS L P?
The average return per transaction made by TYNDALL CAPITAL PARTNERS L P is 47.80%.
What stocks does TYNDALL CAPITAL PARTNERS L P hold?
TYNDALL CAPITAL PARTNERS L P holds: TRAW stocks.
What was TYNDALL CAPITAL PARTNERS L P’s latest transaction?
TYNDALL CAPITAL PARTNERS L P’s latest transaction was an Informative Sell of $19.87K.
What was TYNDALL CAPITAL PARTNERS L P's most profitable transaction?
TYNDALL CAPITAL PARTNERS L P’s most profitable transaction was an Informative Sell of TRAW stock on September 9, 2019. The return on the trade was 91.30%.
What is TYNDALL CAPITAL PARTNERS L P's role in Traws Pharma?
TYNDALL CAPITAL PARTNERS L P's role in Traws Pharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
